Higher fungi in traditional and modern medicine;Höhere pilze in der traditionellen heilkunde und medizin

Medizinische Monatsschrift fur Pharmazeuten

Volumn 33, Issue 2, 2010, Pages 40-48

  Lindequist, Ulrike ^a   Rausch, Rika ^a   Füssel, Anna ^a   Hanssen, Hans Peter ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGARICUS BRASILIENSIS; GANODERMA LUCIDUM; GRIFOLA FRONDOSA; HERICIUM ERINACEUS; LENTINULA EDODES; MUSHROOM; REVIEW; TRADITIONAL MEDICINE;

AGARICALES; ANIMALS; BASIDIOMYCOTA; DRUG THERAPY; FUNGI; GRIFOLA; HUMANS; MEDICINE, TRADITIONAL; REISHI; SHIITAKE MUSHROOMS;

EID: 77249132325     PISSN: 03429601     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Ahn WS, Lee JM, Namkoong SE, Lee IP, et al. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. Int J Gynecol Cancer 2004;14:589-94.
2. Al-Fatimi M, Wurster M, Jansen R, Lindequist U. Bioactive components of the traditionally used mushroom Podaxis pistillaris. ECAM 2006;3:87-92.
3. Bemardshaw S, Johnson E, Hetland G. An extract of the mushroom Agaricus blazei Murill administered orally protects against systemic Streptococcus pneumoniae infection in mice. Scand J Immunol 2005;62:393-8.
4. Boh B, Berovic M, Zhang J, Zhi-Bin L. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Ann Rev 2007;13:265-301.
5. Chen L, Shao HJ, Su YB. Coimmunization of Agaricus blazei Murill extract with hepatitis B virus core protein through DNA vaccine enhances cellular and humoral immune responses. Int Immunopharmacol 2004;4:403-9.
6. Chen L, Shao HJ. Extract from Agaricus blazei Murill can enhance immune responses elicited by DNA vaccine against foot-and-mouth disease. Vet Immunol Immunopathol 2006;109:177-82.
7. Chen SD, Hsieh MC, Chiou MT, Lai YS, et al. Effects of fermentation products of Ganoderma lucidum on growth performance and immuno-competence in weanling pigs. Arch Anim Nutr 2008;62:22-32.
8. Chen X, Hu ZP, Yang XX, Huang M, et al. Monitoring of immune responses to an herbal immunomodulator in patients with advanced colorectal cancer. Int Immunopharmacol 2006;6:499-508.
9. Chen X, Zhong HY, Zeng JH, Ge J. The pharmacological effect of polysaccharides from Lentinus edodes on the oxidative status and expression of VCAM-ImRNA of thoracic aorta endothelial cell in high-fat-diet rats. Carbohydrate Polymers 2008;74:445-50.
10. Chihara G. Medical aspects of lentinan isolated from Lentinus edodes (Berk.) Sing. In: Chang ST, Buswell JA, Chiu SW (editors). Mushroom biology and mushroom products. Hongkong: The Chinese University Press, 1993:261-5.
11. Choi YH, Yan GH, Chai OH, Choi YH, et al. Inhibitory effects of Agaricus blazei on mast cell-mediated anaphylaxis-like reactions. Biol Pharm Bull 2006;29:1366-71.
12. Deng G, Lin H, Seidman A, Fornier M, et al. A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects. J Cancer Res Clin Oncol 2009;135:1215-21.
13. Enman J, Rova U, Berglund KA. Quantification of the bioactive compound eritadenine in selected strains of shiitake mushroom (Lentinula edodes). J Agric Food Chem 2007;55:1177-80.
14. Firenzuoli F, Gori L, Lombardo G. The medicinal mushroom Agaricus blazer Murrill: review of literature and pharmaco-toxicological problems. ECAM 2008;5:3-15.
15. Fukada S, Setoue M, Morita T, Sugiyama K. Dietary eritadenine suppresses guanidinoacetic acid-induced hyperhomocysteinemia in rats. J Nutr 2006;136:2797-802.
16. R) in patients with advanced lung cancer. Int J Med Mushrooms 2003;5:369-81.
17. Gu CQ, Li J, Chao FH. Inhibition of hepatitis B virus by D-fraction from Grifola frondosa: synergistic effect of combination with interferon-alpha in HepG2 2.2.15. Antiviral Res 2006;72:162-5.
18. Hanssen HP, Neugebauer O, Kerscher M. Wirkstoffe aus Pilzen - von der TCM zu neuen Produkten für Kosmetik und Dermatologie. SOFW-Journal 2008;134:7-10.
19. Hazama S, Watanabe S, Ohashi M, Yagi M, et al. Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer. Anticancer Res 2009;29:2611-7.
20. Hong L, Xun M, Wutong W. Anti-diabetic effect of an alpha-glucan from fruit body of maitake (Grifola frondosa) on KK-Ay mice. J Pharm Pharmacol 2007;59:575-82.
21. Huang M, Gao Y, Tang W, Dai X, et al. Immune responses to water-soluble ling zhi mushroom Ganoderma lucidum (W. Curt.: Fr.) P. Karst, polysaccharides in patients with advanced colorectal cancer. Int J Med Mushrooms 2005;7:525-38.
22. Isoda N, Eguchi Y, Nukaya H, Hosho K, et al. Clinical efficacy of superfine dispersed lentinan (beta-1,3-glucan) in patients with hepatocellular carcinoma. Hepato-Gastroenterology 2009;56:437-41.
23. Kawagishi H, Simada A, Shizuki K, Mori H, et al. Erinacine D, a stimulator of NGF-synthesis, from the mycelia of Herinaceum erinaceum. Heterocycles Commun 1996;2:51-4.
24. Kawagishi H, Zhuang C. Bioactive compounds from mushrooms. Heterocycles 2007;72:45-52.
25. Kawagishi H, Zhuang C. Compounds for dementia from Hericium erinaceum. Drugs of the future 2008;33:149-55.
26. Kodama N, Komuta K, Nanba H. Can maitake MD-fraction aid cancer patients? Altern Med Rev 2002;7:236-9.
27. Kodama N, Komuta K, Nanba H. Effect of maitake (Grifola frondosa) D-fraction on the activation of NK cells in cancer patients. J Med Food 2003;6:371-7.
28. Lavi I, Friesen D, Geresh S, Hadar Y, et al. An aqueous polysaccharide extract from the edible mushroom Pleurotus ostreatus induces anti-proliferative and pro-apoptotic effects on HT-29 colon cancer effects. Cancer Lett 2006;4:61-70.
29. Lindequist U, Niedermeyer THJ, Jülich WD. The pharmacological potential of mushrooms. ECAM 2005;2:285-99.
30. Lindequist U. Ganoderma. In: Schneider G, Hansel R, Blaschek W (Hrsg.). HAGERs Handbuch der Pharmazeutischen Praxis. Berlin, Heidelberg, New York: Springer-Verlag, 1998:750-61.
31. Lindequist U. Lentinula. In: Schneider G, Hänsel R, Blaschek W (Hrsg.). HAGERs Handbuch der Pharmazeutischen Praxis. Berlin, Heidelberg, New York: Springer-Verlag, 1998:61-71.
32. Maruyama S, Sukekawa Y, Kaneko Y, Fujimoto S. Antitumor activities of lentinan and micellapist in tumor-bearing mice. Gan To Kagaku Ryoho 2006;33:1726-9 (Abstract in Engl.).
33. Masuda Y, Murata Y, Hayashi M, Nanba H. Inhibitory effect of MD-fraction on tumor metastasis: involvement of NK cell activation and suppression of intercellular adhesion molecule (ICAM)-1 expression in lung vascular endothelial cells. Biol Pharm Bull 2008;31:1104-8.
34. Masuda Y, Inoue M, Miyata A, Mizuno S, et al. Maitake beta-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice. Int Immunopharmacol 2009;9:620-6.
35. Mizuno T. Bioactive substances in Hericium erinaceus (Bull.: Fr.) Pers. (Yamabushitake), and its medicinal utilization. Int J Med Mushrooms 1999;1:105-19.
36. Mori K, Kobayashi C, Tomita T, Inatomi S, et al. Antiatherosclerotic effect of the edible mushrooms Pleurotus eryngii (eringi), Grifolaf frondosa (maitake) and Hypsizygus marmoreus (bunashimeji) in apolipoprotein E-deficient mice. Nutr Res 2008;28:335-12.
37. Mori K, Inatomi S, Ouchi K, Azumi Y, et al. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy Res 2009;23:367-72.
38. Mori K, Obara Y, HirotaM, Azumi Y, et al. Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biol Pharm Bull 2008;31:1727-32.
39. Mothana RAA, Jansen R, Jülich W-D, Lindequist U. Ganomycin A and B, new antimicrobial farnesyl hydroquinones from the basidiomycete Ganoderma pfeifferi. J Nat Prod 2000;63:416-8.
40. Nagai K, Chiba A, Nishino T, Kubota T, et al. Dilinoleoyl-phosphatidy- lethanolamine from Hericium erinaceum protects against ER stress-dependent Neuro2a cell death via protein kinase C pathway. J Nutr Biochem 2006;17:525-30.
41. Nanba H, Kuo K. Effect of maitake D-fraction on cancer prevention. Ann N Y Acad Sci 1997;833:204-7.
42. Nasser AAA, Jansen R, Pilgrim H, Liberra K, et al. Hispolon, a yellow pigment from Inonotus hispidus. Phytochemistry 1996;41:927-9.
43. Ng ML, Yap AT. Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinula edodes) J Altern Complement Med 2002;8:581-90.
44. Niedermeyer THJ, Lindequist U, Mentel R, Gördes D, et al. Terpenoid constituents of Ganoderma pfeifferi Bres. - Isolation of triterpenes and sterols. J Nat Prod 2005;68:1728-31.
45. Oba K, Kobayashi M, Matsui T, KoderaY, et al. Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer. Anti-cancer Res 2009;7:2739-15.
46. Ochiai T, Isono K, Suzuki T, KoideY, et al. Effect of immunotherapy with lentinan on patients survival and immunological parameters in patients with advanced gastric-cancer - results of a multicenter randomized controlled-study. Int J Immunother 1992;8:161-9.
47. Park YS, Lee HS, Won MH, Lee JH, et al. Effect of an exo-polysaccharide from the culture broth of Hericium erinaceus on enhancement of growth and differentiation of rat adrenal nerve cells. Cytotechnology 2002;39:155-62.
48. Paterson RRM. Ganoderma - a therapeutic fungal biofactory. Phytochemistry 2006;67:1985-2001.
49. Sanodiya BS, Thakur BS, Baghel RK, Prasad G, et al. Ganoderma lucidum: a potent pharmacological macofungus. Curr Pharm Biotechnol 2009;10:717-42.
50. Sekiya A, Fukada S, Morita T, Kawagishi H, et al. Suppression of methionine-induced hyperhomocysteinemia by dietary eritadenine in rats. Biosci Biotechnol Biochem 2006;70:1987-91.
51. Shiao MS. Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions. Chem Rec 2003;3:172-80.
52. Shimada Y, Yamakawa A, Morita T, Sugiyama K. Effects of dietary eritadenine on the liver microsomal Δ6-desaturase activity and its mRNA in rats. Biosci Biotechn Biochem 2003;66:1605-9.
53. Shimizu K, Watanabe S, Watanabe S, Matsuda K, et al. Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer. Hepato-Gastroenterology 2009;56:240-4.
54. Sliva D. Ganoderma lucidum (reishi) in cancer treatment. Integr Cancer Ther 2003;2:358-64.
55. Suzuki S, Ohshima S. Influence of shiitake (Lentinus edodes) on human serum cholesterol. Mushroom Sci 1976;9:463-7.
56. Takimoto H, Kato H, Kaneko M, Kumzawa Y. Amelioration of skewed Th1/Th2 balance in tumor-bearing and asthma-induced mice by oral administration of Agaricus blazei extracts. Immunopharmacol lmmunotoxicol 2008;30:747-60.
57. Talcott JA, Clark JA, Lee IP. Measuring perceived effects of drinking an extract of basidomycetes Agaricus blazei Murrill: a survey of Japanese consumers with cancer. BMC Complement Altern Med 2007;7:32.
58. Tang W, Gao YH, Chen GL, Gao H, et al. A randomized, double-blind and placebo-controlled study of Ganoderma lucidum polysaccharide extract in neurasthenia. J Med Food 2005;8:53-8.
59. Ueda K, Tsujimori M, Kodani S, Chiba A, et al. An endoplasmic reticulum (ER) stress-suppressive compound and its analogues from the mushroom Hericium erinaceum. Bioorg Med Chem 2008;16:9467-70.
60. Wasser SP, Weis AL. Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspectives [review]. Int J Med Mushrooms 1999;1:31-62.
61. Wong KH, Naidu M, David RP, Abdulla MA, et al. Functional recovery enhancement following injury to rodent peroneal nerve by lion's man mushroom, Hericium erinaceus (Bull.: Fr.) Pers. (Aphyllophoromycetidae). Int J Med Mushrooms 2009;11:225-36.
62. Yamada T, Oinuma T, Niihashi M, Mitsumata M, et al. Effects of Lentinus edodes mycelia on dietary-induced atherosclerotic involvement in rabbit aorta. J Atheroscler Thromb 2002;9:149-56.
63. Yap AT, Ng ML. Immunopotentiating properties of lentinan (1-3)-β-D-glucan extracted from culinary-medicinal Shiitake mushroom Lentinus edodes (Berk.) Singer (Agaricomycetidae). Int J Med Mushrooms 2003;5:339-58.
64. Yap AT, Ng ML. The medicinal benefits of lentinan (β-1,3-D-glucan) from Lentinus edodes (Berk.) Singer (shiitake mushroom) through oral administration. Int J Med Mushrooms 2005;7:175-83.
65. Yoshimura K, Ueda N, Ichioka K, Matsui Y, et al. Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution. Support Care Cancer 2005;13:685-90.
66. Zhuang C, Mizuno T. Biological responses from Grifola frondosa. Int J Med Mushrooms 1999;1:317-24.
67. Zhang L, Li X, Xu X, Zeng F. Correlation between antitumor activity, molecular weight, and conformation of lentinan. Carbohydrate Res 2005;340:1515-21.